Meta-analysis of the transforming growth factor-β1 polymorphisms and susceptibility to Alzheimer's disease

Journal of Neural Transmission

Volumn 120, Issue 2, 2013, Pages 353-360

  Chang, Wei Wei ^a   Zhang, Liu ^b   Jin, Yue Long ^a   Yao, Ying Shui ^a  

^a WANNAN MEDICAL COLLEGE   (China)

^b Wuhu Hospital of Traditional Chinese Medicine   (China)

Author keywords

AD; Meta analysis; Polymorphism; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ALZHEIMER DISEASE; CASE CONTROL STUDY; DNA POLYMORPHISM; ETHNICITY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOTE; HUMAN; INFORMATION RETRIEVAL; META ANALYSIS (TOPIC); PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ALLELES; ALZHEIMER DISEASE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84878400313     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-012-0850-7     Document Type: Review

References (43)

1. Araria-Goumidi L, Lambert JC, Mann DM, Lendon C, Frigard B, Iwatsubo T, Cottel D, Amouyel P, Chartier-Harlin MC (2002) Association study of three polymorphisms of TGF-beta1 gene with Alzheimer's disease. J Neurol Neurosurg Psychiatry 73:62-64
2. Arosio B, Bergamaschini L, Galimberti L, La Porta C, Zanetti M, Calabresi C, Scarpini E, Annoni G, Vergani C (2007) +10T/C polymorphisms in the gene of transforming growth factor-beta1 are associated with neurodegeneration and its clinical evolution. Mech Ageing Dev 128:553-557
3. Bertram L, Tanzi RE (2008) Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 9:768-778
4. Cacquevel M, Lebeurrier N, Che'enne S, Vivien D (2004) Cytokines in neuroinflammation and Alzheimer's disease. Curr Drug Targets 5:529-534
5. Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, Poirier O (1996) Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 28(5):881-887
6. Caraci F, Battaglia G, Busceti C, Biagioni F, Mastroiacovo F, Bosco P, Drago F, Nicoletti F, Sortio MA, Copani A (2008) TGF-beta 1 protects against Abeta-neurotoxicity via the phosphatidylinositol-3-kinase pathway. Neurobiol Dis 30:234-242
7. Caraci F, Copani A, Nicoletti F, Drago F (2010) Depression and Alzheimer's disease: neurobiological links and common pharmacological targets. Eur J Pharmacol 626:64-71
8. Caraci F, Battaglia G, Bruno V, Bosco P, Carbonaro V, Giuffrida ML, Drago F, Sortino MA, Nicoletti F, Copani A (2011) TGF-beta1 pathway as a new target for neuroprotection in Alzheimer's disease. CNS Neurosci Ther 17:237-249
9. Caraci F, Bosco P, Signorelli M, Spada RS, Cosentino FI, Toscano G, Bonforte C, Muratore S, Prestianni G, Panerai S, Giambirtone MC, Gulotta E, Romano C, Salluzzo MG, Nicoletti F, Copani A, Drago F, Aguglia E, Ferri R (2012) The CC genotype of transforming growth factor-β1 increases the risk of late-onset Alzheimer's disease and is associated with AD-related depression. Eur Neuropsychopharmacol 22(4):281-289
10. Castren E, Tanila H (2006) Neurotrophins and dementia - keeping in touch. Neuron 51:1-3
11. Cousin E, Macé S, Rocher C, Dib C, Muzard G, Hannequin D, Pradier L, Deleuze JF, Génin E, Brice A, Campion D (2011) No replication of genetic association between candidate polymorphisms and Alzheimer's disease. Neurobiol Aging 32(8):1443-1451
12. DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28:105-114
13. Dickson MR, Perry RT, Wiener H, Go RC (2005) Association studies of transforming growth factor-beta 1 and Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 139B:38-41
14. DiRosa M, Dell'Ombra N, Zambito AM, Malaguarnera M, Nicoletti F, Malaguarnera L (2006) Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia. Eur J Neurosci 23:2648-2656
15. Flanders KC, Lippa CF, Smith TW, Pollen DA, Sporn MB (1995) Altered expression of transforming growth factor-beta in Alzheimer's disease. Neurology 45:1561-1569
16. Fujii D, Brissenden J, Derynck R, Francke U (1986) Transforming growth factor-beta gene maps to human chromosome 19 long arm and to mouse chromosome 7. Somat Cell Mol Genet 12:281-288
17. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD (1999) Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8:93-97
18. Hamaguchi T, Okino S, Sodeyama N, Itoh Y, Takahashi A, Otomo E, Matsushita M, Mizusawa H, Yamada M (2005) Association of a polymorphism of the transforming growth factor-beta1 gene with cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry 76:696-699
19. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356
20. Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558
21. Lahiri DK, Ge YW, Maloney B (2005) Characterization of the APP proximal promoter and 50 untranslated regions: identification of cell-type specific domains and implications in APP gene expression and Alzheimer's disease. FASEB J 19(6):653-655
22. Luedecking EK, DeKosky ST, Mehdi H, Ganguli M, Kamboh MI (2000) Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease. Hum Genet 106:565-569
23. Luterman JD, Haroutunian V, Yemul S, Ho L, Purohit D, Aisen PS, Mohs R, Pasinetti GM (2000) Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch Neurol 57:1153-1160
24. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
25. Mosseau DD, Chapelsky S, De Crescenzo G, Kirkitadze MD, Magoon J, Inoue S, Teplow DB, O'Connor-McCourt MD (2003) A direct interaction between transforming growth factor (TGF)-betas and amyloid-beta protein affects fibrillogenesis in a TGF-beta receptor-independent manner. J Biol Chem 278:387715-438722
26. Nishimura M, Sakamoto T, Kaji R, Kawakami H (2004) Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease. Neurosci Lett 368:140-143
27. Paul SR, Donner A (1992) Small sample performance of tests of homogeneity of odds ratios in K 2 × 2 tables. Stat Med 11:159-165
28. Peila R, Yucesoy B, White LR, Johnson V, Kashon ML, Wu K, Petrovitch H, Luster M, Launer LJ (2007) A TGF-beta1 polymorphism association with dementia and neuropathologies: the HAAS. Neurobiol Aging 28:1367-1373
29. Ribizzi G, Fiordoro S, Barocci S, Ferrari E, Megna M (2010) Cytokine polymorphisms and Alzheimer disease: possible associations. Neurol Sci 31:321-325
30. Rodríguez-Rodríguez E, Sánchez-Juan P, Mateo I, Llorca J, Infante J, García-Gorostiaga I, Berciano J, Combarros O (2007) Serum levels and genetic variation of TGF-beta1 are not associated with Alzheimer's disease. Acta Neurol Scand 116:409-412
31. Rojo LE, Fernández JA, Maccioni AA, Jimenez JM, Maccioni RB (2008) Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Arch Med Res 39:1-16
32. Schellenberg GD, Montine TJ (2012) The genetics and neuropathology of Alzheimer's disease. Acta Neuropathol. doi: 10.1007/s00401-012-0996-2
33. Shawkatová I, Javor J, Párnická Z, Vražda L, Novák M, Buc M (2010) No association between cytokine gene polymorphism and risk of Alzheimer's disease in Slovaks. Acta Neurobiol Exp 70:303-307
34. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, August P (2000) Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: a novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA 97(7):3479-3484
35. Tarkowski E, Issa R, Sjogren M, Wallin A, Blennow K, Tarkowski A, Kumar P (2002) Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging 23:237-243
36. van der Wal EA, Gomez-Pinilla F, Cotman CW (1993) Transforming growth factor-β1 is in plaques in Alzheimer and down pathologies. Neuro Report 4:69-72
37. Van Oijen M, Arp PP, De Jong FJ, Hofman A, Koudstaal PJ, Uitterlinden AG, Breteler MM (2006) Polymorphisms in the interleukin 6 and transforming growth factor beta1 gene and risk of dementia. The Rotterdam Study. Neurosci Lett 402:113-117
38. Vina J, Lloret A (2010) Why women have more Alzheimer's disease than men: gender and mitochondrial toxicity of amyloid-beta peptide. J Alzheimers Dis 20:S527-S533
39. Walsh DM, Selkoe DJ (2007) A beta oligomers - a decade of discovery. J Neurochem 101:1172-1184
40. Wang YP, Ye JP, Liu XJ, Huang SK, Chen SQ (2010) Analysis of the T869C and/or C-509T polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease. New Med 41:463-465 (Chinese)
41. Wyss-Coray T (2006) Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's. Curr Alzheimer Res 3:191-195
42. Ye JP, Huang SK, Chen SQ, Liu XJ, Wang YP (2010) Analysis of the T869C polymorphism in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease. Anat Res 32:93-95 (Chinese)
43. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y (2000) Association of a T29→C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 101(24):2783-2787